IGHE and allergic disease: Using CRD, a patient’s IgE reactivity profile allows for more accurate risk assessment of the severity of systemic reactions and persistence of allergy, the identification of serological or potential clinical cross-reactivity, the monitoring of ongoing allergen immunotherapy, or provides data on the prevalence of sensitization (1–3).